Orange Book product · Generic (ANDA)
DOXEPIN HYDROCHLORIDE
DOXEPIN HYDROCHLORIDE
At a glance
Aug 16, 2023
Approved
Generic (ANDA)
Application
AB
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Aug 16, 2023
2 yr 11 mo ago
Today
Pharmaceutical detail
Active ingredient
DOXEPIN HYDROCHLORIDE
Strength
5%
Dosage form
CREAM
Route
TOPICAL
TE code
AB
Application
ANDA 212357
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of DOXEPIN HYDROCHLORIDE
- —DOXEPIN HYDROCHLORIDEBrand (NDA)
NDA 016987 · NEW RIVER
- 2023DOXEPIN HYDROCHLORIDEGeneric (ANDA)
ANDA 217975 · UNIQUE
- 2023DOXEPIN HYDROCHLORIDEGeneric (ANDA)
ANDA 217688 · MICRO LABS
- 2022DOXEPIN HYDROCHLORIDEGeneric (ANDA)
ANDA 215113 · MSN
- 2022DOXEPIN HYDROCHLORIDEGeneric (ANDA)
ANDA 213796 · ADAPTIS
- 2022DOXEPIN HYDROCHLORIDEGeneric (ANDA)
ANDA 215483 · JUBILANT CADISTA
- 2022DOXEPIN HYDROCHLORIDEGeneric (ANDA)
ANDA 215710 · MANKIND PHARMA
- 2021DOXEPIN HYDROCHLORIDEGeneric (ANDA)
ANDA 215076 · ALEMBIC
- 2021DOXEPIN HYDROCHLORIDEGeneric (ANDA)
ANDA 214908 · APPCO
- 2021DOXEPIN HYDROCHLORIDEGeneric (ANDA)
ANDA 211619 · IXORA LIFESCIENCE
- 2021DOXEPIN HYDROCHLORIDEGeneric (ANDA)
ANDA 211618 · VELZEN PHARMA PVT
- 2020DOXEPIN HYDROCHLORIDEGeneric (ANDA)
ANDA 210675 · EPIC PHARMA LLC
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
